Logo
HYALUAL Electri 0.55% 1x1.5ml

HYALUAL Electri 0.55% 1x1.5ml

HYALUAL

Injectable mesotherapy / skin booster
  • CE Marked injectable medical device based on non Crosslinked hyaluronic acid and sodium succinate.
  • Manufactured in accordance with international quality standards (ISO) as stated in official product literature.
  • Formulation contains only components naturally present in the human body, supporting high biocompatibility and safety profile.
  • Intended for professional use under applicable medical device and aesthetic medicine regulations in relevant markets.
Non-crosslinked hyaluronic acid and succinic acid injectable for skin revitalisation and redermalisation

Description

HYALUAL Electri is a professional injectable mesotherapy (biorevitalisation) product based on a synergistic combination of non-crosslinked high-molecular-weight hyaluronic acid (0.55%) and sodium succinate (succinic acid salt) 1.6%. Designed as a \first injection\ or single-session skin booster, it provides intensive skin restoration with natural moisturisation, visible complexion improvement, normalised microcirculation and structural skin improvement, without a long rehabilitation period. Supplied as a sterile 1.5 ml prefilled syringe with 30G needles, Electri is suitable for women and men of any age and targets dehydration, early signs of ageing, dullness, loss of turgor and hyperpigmentation on the face, neck and décolleté, including the delicate eye area by experienced injectors.

Bnefits

  • Provides rapid, intensive skin hydration with measurable moisture increase (up to normal levels after a single treatment, according to manufacturer data).
  • Improves overall skin tone and texture, restoring a healthy, radiant complexion.
  • Helps normalise dermal microcirculation and cellular energy exchange via sodium succinate.
  • Improves skin turgor, firmness and elasticity, reducing the appearance of fine, superficial wrinkles.
  • Helps reduce hyperpigmentation and uneven skin tone, including "tired", smoker’s or sun-damaged skin.
  • Offers antioxidant protection in dermal cells, helping slow the early skin-ageing process.
  • Physiological concentration of HA (0.55%) allows easy injection, quick absorption and minimal papules or prolonged swelling.
  • Short downtime with fast visible results after a single session, suitable for busy patients.
  • CE-marked, ISO-standard manufactured and composed only of substances naturally present in the human body for high biocompatibility and safety.

Indications

  • Skin dehydration and loss of moisture.
  • Microcirculation disorders in the dermal vessels.
  • Decreased skin turgor and early loss of elasticity.
  • Tired, dull, "smoker’s" or photo-damaged skin lacking radiance.
  • Superficial fine wrinkles and early signs of ageing.
  • Uneven complexion, loss of healthy skin colour and glow.
  • Hyperpigmentation and mild discolouration.
  • Skin needing revitalisation after sun exposure or aggressive cosmetic procedures.
  • Prevention of premature skin ageing in men and women of various ages.

Composition

  • Sodium succinate (succinic acid) 1.6%.
  • High-molecular-weight hyaluronic acid 0.55% (5.5 mg/ml; 8.25 mg per 1.5 ml syringe).
  • Physiological buffer solution (sodium chloride and water for injection).

Formulation

  • Injectable solution based on non-crosslinked high-molecular-weight hyaluronic acid and sodium succinate.
  • Physiological concentration of HA (0.55%) to ensure quick absorption and minimal papule formation.
  • Double Synergic Effect Technology: combined action of hyaluronic acid and sodium succinate providing moisturising, antioxidant, microcirculation-normalising and structural benefits.
  • Sterile, pyrogen-free, transparent solution supplied in a single-use 1.5 ml glass syringe.
  • Intended for intradermal injection using papular or microinjection techniques by trained professionals.

Packaging

  • Box containing 1 x 1.5 ml prefilled sterile syringe of HYALUAL Electri 0.55%.
  • Set of 30G needles included in each pack.
  • Sterile blister packaging for syringe and needles.
  • Instructions for use / product leaflet with protocol and safety information.

Usage

  • For professional use only: administer only by trained healthcare professionals or aesthetic practitioners experienced in injectable mesotherapy and facial anatomy.
  • Assess patient history, indications and contraindications; obtain informed consent prior to treatment.
  • Cleanse and disinfect the treatment area thoroughly. Degrease the skin if needed to improve injection control and visibility.
  • Inject Electri intradermally using papular or microinjection technique, typically in zones such as forehead, periorbital area (by experienced practitioners), perioral area, chin, cheeks, neck and décolleté, following the manufacturer’s recommended protocol.
  • Use the supplied 30G needles, injecting small aliquots at appropriate spacing; avoid intravascular injection and follow standard aseptic injection techniques.
  • Electri is often used as a single-session treatment for intensive skin regeneration; protocols may also include occasional repeat sessions depending on patient needs and practitioner judgement.
  • After injection, gently pat or lightly massage the treated area only if required, avoiding excessive pressure, especially around the eye area.
  • Advise patients to avoid makeup on the treated area for several hours post-procedure and to minimise sun exposure, saunas, very hot showers and vigorous exercise for 24–48 hours.
  • Recommend daily broad-spectrum sunscreen and gentle skincare after treatment to maintain results and minimise risk of post-procedural pigmentation.
  • Always refer to the latest official HYALUAL Electri instructions for detailed protocol, dosing recommendations and combination options with other procedures.

Contraindications

  • Known hypersensitivity or allergy to hyaluronic acid, sodium succinate/succinic acid or any component of the product.
  • Acute or chronic skin infections, inflammatory skin diseases or lesions at or near the intended injection sites (e.g. active herpes, dermatitis, severe acne flare).
  • Autoimmune diseases or severe systemic disease where injectable aesthetic procedures are considered unsafe by the treating physician.
  • Coagulation disorders or ongoing anticoagulant/antiplatelet therapy where injection-associated bleeding risk is not acceptable (subject to prescriber risk assessment).
  • Pregnancy and breastfeeding (use is generally avoided due to lack of safety data).
  • History of severe allergic reactions or anaphylaxis.
  • Known tendency to keloid or hypertrophic scar formation in the intended treatment area without careful risk–benefit assessment.
  • Recent aggressive cosmetic procedures (deep peels, ablative lasers, dermabrasion) on the treatment area without adequate healing time.
  • Any other condition that, in the professional judgement of the practitioner, makes injectable mesotherapy inappropriate.

Adverse Effects

  • Common, usually transient injection-site reactions including redness, swelling, tenderness, bruising, itching or mild pain.
  • Temporary papules or small bumps at injection points, usually resolving as the product integrates into the tissue.
  • Mild oedema, especially in delicate areas such as the periorbital region.
  • Haematoma or ecchymosis at injection sites.
  • Local inflammatory or hypersensitivity reactions; in rare cases, delayed inflammatory responses may occur.
  • Very rare but potential complications of injectable procedures, such as infection, persistent nodules or granulomatous reactions, which may require medical treatment.
  • As with any injectable near vascular structures, there is a theoretical risk of vascular events if product is inadvertently injected intravascularly; practitioners must follow safe injection techniques and be prepared to manage complications.

Storage Conditions

  • Store between approximately 2°C and 25°C (as specified by distributors and manufacturer).
  • Do not freeze. Protect from excessive heat and direct sunlight.
  • Keep the product in its original packaging until use to preserve sterility and stability.
  • Do not use after the expiry date indicated on the packaging.
  • Do not use if the syringe, needles or blister packaging are damaged or previously opened.
  • Single-use medical device: discard any unused product, syringe and needles after the procedure according to local regulations for sharps and clinical waste.

Duration

Manufacturer and distributor data indicate that the results of a single HYALUAL Electri treatment typically last around 3\u20134 months, with sustained improvements in hydration, texture, tone and radiance. Duration can vary based on age, skin condition, lifestyle and maintenance treatments.

Onset

Visible improvements in hydration, skin glow and fine lines are usually seen shortly after the first procedure, with an express effect of hydration and brightening noted within days. Structural changes and further refinement of texture and tone develop over the following weeks as dermal regeneration progresses.

Browse more Injectable mesotherapy / skin booster

Top Treatments

Top Cities in the UK